Nicholas D Kindon

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Regulatory T Cells

Energy Transfer

Top Venues

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)